Effects of zidovudine treatment on the small intestinal mucosa in patients infected with the human immunodeficiency virus

Gastroenterology

Volumn 102, Issue 5, 1992, Pages 1483-1492

  Ullrich, Reiner ^a,b   Heise, Walter ^a,b   Bergs, Clemens ^a,b   L'age, Manfred ^a,b   Riecken, Ernst Otto ^a,b   Zeitz, Martin ^a,b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b Vivantes Auguste Viktoria Klinikum   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANTIGEN P24; BETA GLUCOSIDASE; LACTASE; ZIDOVUDINE;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; BLOOD TOXICITY; CELL GROWTH; CONTROLLED STUDY; DRUG EFFECT; DUODENUM BIOPSY; ENZYME ACTIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; INTESTINE ABSORPTION; INTESTINE BRUSH BORDER; INTESTINE CELL; INTESTINE CRYPT; MALE; PRIORITY JOURNAL; SMALL INTESTINE MUCOSA; VIRUS INFECTION; WEIGHT GAIN;

ADULT; BETA-GALACTOSIDASE; BETA-GLUCOSIDASE; FEMALE; HIV INFECTIONS; HUMAN; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; MICROVILLI; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T; ZIDOVUDINE;

EID: 0026538163     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(92)91705-9     Document Type: Article

References (35)

1. Non-opportunistic causes of diarrhoea in HIV infection
2. Nutritional status, gastrointestinal dysfunction, and survival in patients with AIDS
3. Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy
4. HIV-associated enteropathy
5. Quantitative histological study of enteropathy associated with HIV infection
6. Mucosal atrophy is associated with loss of activated T cells in the duodenal mucosa of human immunodeficiency virus (HIV)-infected patients
7. Administration of 3′-azido-3′-deoxythymidine, an inhibitor of HTLVIII/LAV replication, to patients with AIDS or AIDS-related complex
8. The efficacy of azidothymidin (AZT) in the treatment of patients with AIDS and AIDS-related complex
9. Effects of zidovudine in 365 consecutive patients with AIDS or AIDS-related complex
10. Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex
11. The efficacy and toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex (ARC): an open uncontrolled treatment study
12. Resolution of intestinal cryptosporidiosis after treatment of AIDS with AZT
13. Treatment of intestinal cryptosporidiosis in AIDS
14. The toxicity of azidothymidin (AZT) in the treatment of patients with AIDS and AIDS-related complex
15. Nature, time course and dose dependence of zidovudine-related side effects: results from the multicenter Canadian azidothymidine trial
16. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections
17. Leads from the MMWR (Morbidity and Mortality Weekly Report) Supplement 15 Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome
18. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)
19. Kinetic characterization of unspecific alkaline phosphatase at different villus sites of rat jejunum
20. max of brush border disaccharidases along the villi of normal human jejunal biopsy specimens
21. Mucosal architecture and epithelial cell production rate in the small intestine of the albino rat
22. Enteropathy associated with the acquired immunodeficiency syndrome
23. HIV-induced enteropathy
24. AIDS enteropathy: occult enteric infections and duodenal mucosal alterations in chronic diarrhea
25. Jejunal enteropathy associated with human immunodeficiency virus infection: quantitative histology
26. Detection of HIV-1 RNA in the lamina propria of patients with AIDS and gastrointestinal disease
27. Infected cells and immune cells in the gastrointestinal tract of AIDS patients. An immunohistochemical study of 127 cases
28. Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms
29. Role of cytokines in infectious and noninfectious enteropathy in patients with AIDS
30. 3′-Azido-3′-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro
31. Phosphorylation of 3′-azido-3′-deoxythimidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase
32. The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic marker
33. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter
34. A pilot study of low-dose zidovudine in human immunodeficiency virus infection